tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of John Walsh, 96 are a HOLD (35.29%), 162 are a BUY (59.56%), 14 are a SELL (5.15%).
Analyst John Walsh, currently employed carries an average stock price target met ratio of 65.54% that have a potential upside of 23.27% achieved within 247 days. Previously, John Walsh worked at CREDIT SUISSE.
John Walsh’s has documented 570 price targets and ratings displayed on 36 stocks. The coverage was on Industrials, Technology, Basic Materials, Healthcare sectors.
Most recent stock forecast was given on PNT, POINT Biopharma Global at 04-Oct-2023.
Analyst best performing recommendations are on GTLS (CHART INDUSTRIES).
The best stock recommendation documented was for GTLS (CHART INDUSTRIES) at 10/13/2020. The price target of $80 was fulfilled within 1 day with a profit of $4.69 (6.23%) receiving and performance score of 62.28.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
$137
$-2.53 (-1.81%)
$135
24 days ago
(28-Oct-2024)
16/21 (76.19%)
$-5.33 (-3.74%)
286
Hold
$152
$12.47 (8.94%)
$116
27 days ago
(25-Oct-2024)
13/14 (92.86%)
$9.4 (6.59%)
428
Hold
$150
$10.47 (7.50%)
$141
1 months 4 days ago
(17-Oct-2024)
8/9 (88.89%)
$-2.48 (-1.63%)
308
Hold
$100
$-39.53 (-28.33%)
$128
1 years 1 months 2 days ago
(19-Oct-2023)
2/2 (100%)
$2.56 (2.63%)
208
$127
$-12.53 (-8.98%)
$120
1 years 3 months 25 days ago
(27-Jul-2023)
23/23 (100%)
$13.29 (11.69%)
285
What Year was the first public recommendation made by John Walsh?
